Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Mydecine Innovations Group Inc. AGM Information 2021

Jul 15, 2021

47221_rns_2021-07-15_a7ff38c0-18b9-4c43-bae2-02f350b7ad9d.pdf

AGM Information

Open in viewer

Opens in your device viewer

MYDECINE INNOVATIONS GROUP INC.

FILED ON SEDAR

July 15, 2021

TO ALL REGULATORS AND EXCHANGES

RE: MYDECINE INNOVATIONS GROUP INC. (the "Issuer") Notice of Meeting and Record Dates

We advise the following with respect to the Issuer's upcoming Meeting of Security Holders

1MeetingType Annual General Meeting
2Record Date for Notice of Meeting August 9,2021
3Record Date for Voting (If Applicable) August 9,2021
4Beneficial OwnershipDetermination Date August 9,2021
5MeetingDate September 13, 2021
6Meeting Location Suite 810 – 789 West Pender StreetVancouver, BC, V6C 1H2
7VotingSecurities Details
8Description(Class) Common
9ISIN / CUSIP CA62848R1064 / 62848R106
10Issuer sending proxy related materials directly to Non-ObjectingBeneficial Owners(NOBO's) NO
11Issuer paying for delivery of Objecting BeneficialOwners(OBO's) NO
12Notice and Access
Beneficial Holders NO
Registered Holders NO
13Material Selection Annual Meeting: G - All Material

Yours Truly,

"Joshua Bartch"


Joshua Bartch, CEO Mydecine Innovations Group Inc.